(Press-News.org)
“The patient was managed with ripretinib and surgical resection of progressing lesions at multiple time points which led to extended clinical benefit.”
BUFFALO, NY- November 3, 2023 – A new case report was published in Oncoscience (Volume 10) on September 20, 2023, entitled, “Multi-disciplinary management of recurrent gastrointestinal stromal tumor harboring KIT exon 11 mutation with the switch-control kinase inhibitor ripretinib and surgery.”
Ripretinib is a tyrosine kinase inhibitor that was approved by the United States FDA in 2020 for treatment of advanced gastrointestinal stromal tumor (GIST) in patients who received prior treatment with three or more tyrosine kinase inhibitors.
In this new case report, researchers Mohamed A. Gouda, Filip Janku, Neeta Somaiah, Kelly K. Hunt, Sireesha Yedururi, and Vivek Subbiah from The University of Texas MD Anderson Cancer Center and Sarah Cannon Research Institute described the use of ripretinib in a patient with recurrent GIST harboring a KIT exon 11 mutation following treatment with multiple TKIs. The patient was managed with ripretinib and surgical resection of progressing lesions at multiple time points which led to extended clinical benefit.
“[...] we show the durable clinical benefit achieved in a patient with GIST by using ripretinib and repeated timely surgical resection of limited disease progression.”
A Hispanic female in her late 20s presented with left lower quadrant pain initially attributed to an ovarian cyst. A workup with computed tomography (CT) evaluation, revealed an incidental 6 cm duodenal mass with central necrosis. She underwent exploratory laparotomy with resection of the mass which was diagnosed as GIST with high malignant potential and positive immunohistochemistry for c-KIT. The total time on ripretinib was 43 months which is longer than the current reported data from ripretinib clinical trials.
“Such an approach for using multi-disciplinary disease management can improve the durability of response to tyrosine kinase inhibitors, including ripretinib, and associated clinical outcomes.”
Read the full paper: DOI: https://doi.org/10.18632/oncoscience.586
Correspondence to: Vivek Subbiah
Email: vivek.subbiah@scri.com
Keywords: ripretinib, precision oncology, sarcoma, surgery
About Oncoscience:
Oncoscience is a peer-reviewed, open-access, traditional journal covering the rapidly growing field of cancer research, especially emergent topics not currently covered by other journals. This journal has a special mission: Freeing oncology from publication cost. It is free for the readers and the authors.
To learn more about Oncoscience, visit Oncoscience.us and connect with us on social media:
X, formerly known as Twitter
Facebook
YouTube
LinkedIn
For media inquiries, please contact media@impactjournals.com.
Oncoscience Journal Office
6666 East Quaker Str., Suite 1D
Orchard Park, NY 14127
Phone: 1-800-922-0957, option 4
###
END
Health happens where people work, live, play and worship, says Prof. Stacey Snelling, chair of the Department of Health Studies in American University’s College of Arts and Sciences. And that’s where the Healthy Schools, Healthy Communities Lab engages children, adults and older adults to tackle health inequities. Snelling received a three-year grant of $2.8 million from Novo Nordisk Inc. for health education and to grow the number of Black farmers producing locally grown fruit and vegetables. The goal is to improve local ...
BOSTON – Ready or not, patients with cancer are increasingly likely to find themselves interacting with artificial intelligence technologies to schedule appointments, monitor their health, learn about their disease and its treatment, find support, and more. In a new paper in JCO Oncology Practice, bioethics researchers at Dana-Farber Cancer Institute call on medical societies, government leaders, clinicians, and researchers to work together to ensure AI-driven healthcare preserves patient autonomy and respects human dignity.
The authors note that while AI has immense potential for expanding access to cancer care and improving the ...
Researchers at Weill Cornell Medicine have led a phase 1 trial of a new drug that delivers potent radiation therapy directly and specifically to cancer cells in patients with advanced prostate cancer. The clinical trial showed that the “radiopharmaceutical” was well tolerated and demonstrated promising antitumor activity, according to a new study published on Nov. 2 in the Journal of Clinical Oncology.
The radiopharmaceutical 225AC-J591 was administered in a single injection and consists of two parts: an antibody that helps find the cancer cells is linked to a molecule that delivers a deadly dose of radiation. Specifically, an antibody named J591 that ...
MINNEAPOLIS/ST. PAUL (11/03/2023) — Research led by the University of Minnesota Medical School identified a new pathway to combat cardiovascular disease. The study was recently published in Nature Cardiovascular Research.
The research team’s work identifies a molecule called TREM2 as a unique and therapeutically relevant pathway for the treatment of atherosclerosis—a common condition that develops when plaque builds up inside arteries—in preclinical models. Atherosclerosis is a primary cause of cardiovascular diseases, which are the number one ...
CHICAGO—November 3, 2023—Illinois Institute of Technology (Illinois Tech) has leased approximately 34,295 square feet in Trammell Crow Company’s (TCC) Fulton Labs innovation hub, announced today by the Chicago office of TCC, a global real estate developer. Illinois Tech will occupy the entire 7th floor of the cutting-edge wet lab facilities at 400 North Aberdeen, aiming to fuel scientific breakthroughs and industry-relevant research as the first academic institution to join the thriving and collaborative innovation ecosystem alongside their Fulton Labs neighbors, which include Portal Innovations and the Chan Zuckerberg BioHub. ...
Ever since the discovery of the Higgs boson in 2012, physicists have wanted to build new particle colliders to better understand the properties of that elusive particle and probe elementary particle physics at ever-higher energy scales.
The trick is, doing so takes energy – a lot of it. A typical collider takes hundreds of megawatts – the equivalent of tens of millions of modern lightbulbs – to operate. That's to say nothing of the energy it takes to build the devices, and it all adds ...
November 3, TORONTO — Scientists at the Ontario Institute for Cancer Research (OICR) have uncovered one way tobacco smoking causes cancer and makes it harder to treat by undermining the body’s anti-cancer safeguards.
Their new study, published today in Science Advances, links tobacco smoking to harmful changes in DNA called ‘stop-gain mutations’ that tell the body to stop making certain proteins before they are fully formed.
They found that these stop-gain mutations were especially prevalent in genes known as ‘tumour-suppressors’, ...
Joint press release by MARUM - Center for Marine Environmental Sciences at the University of Bremen and GEOMAR Helmholtz Centre for Ocean Research Kiel
The distribution of salt by ocean currents plays a crucial role in regulating the global climate. This is what researchers from Dalhousie University in Canada, GEOMAR Helmholtz Centre for Ocean Research Kiel, Alfred Wegener Institute, Helmholtz Centre for Polar and Marine Research (AWI) and MARUM – Center for Marine Environmental Sciences at the University of Bremen have found in a new study. ...
The connection between exercise and inflammation has captivated the imagination of researchers ever since an early 20th-century study showed a spike of white cells in the blood of Boston marathon runners following the race.
Now, a new Harvard Medical School study published Nov. 3 in Science Immunology may offer a molecular explanation behind this century-old observation.
The study, done in mice, suggests that the beneficial effects of exercise may be driven, at least partly, by the immune system. It shows that muscle inflammation caused by exertion mobilizes inflammation-countering T cells, or Tregs, which enhance the muscles’ ability to use ...
There are many creatures on our planet with more advanced senses than humans. Turtles can sense Earth’s magnetic field. Mantis shrimp can detect polarized light. Elephants can hear much lower frequencies than humans can. Butterflies can perceive a broader range of colors, including ultraviolet (UV) light.
Inspired by the enhanced visual system of the Papilio xuthus butterfly, a team of researchers have developed an imaging sensor capable of “seeing” into the UV range inaccessible to human eyes. The design of the sensor uses stacked photodiodes and perovskite nanocrystals (PNCs) capable of imaging different wavelengths ...
